Showing 20 of 200 recruiting trials for “large-granular-lymphocyte-leukemia”
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Enrolling by InvitationNCT05509855 ↗
A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
RecruitingNCT05334069 ↗
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 144 sites📅 Started Jul 2022View details ↗
RecruitingNCT04785989 ↗
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
👨⚕️ Christopher Fletcher, MD, School of Medicine and Public Health, University of Wisconsin, Madison📍 1 site📅 Started Jun 2022View details ↗
RecruitingNCT05750706 ↗
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
👨⚕️ Marianna Criscuolo, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jun 2022View details ↗
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
👨⚕️ Barbara Eichhorst, MD, Prof., Department I of Internal Medicine, University Hospital Cologne📍 30 sites📅 Started Apr 2022View details ↗
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingNCT05840575 ↗
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Bright Ideas - CIN Feasibility Study
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
👨⚕️ Daniel Ermann, MD, Huntsman Cancer Institute/ University of Utah📍 1 site📅 Started Jan 2022View details ↗
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
RecruitingNCT05014165 ↗
Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
👨⚕️ Adam de Smith, PhD, University of Southern California Keck School of Medicine📍 1 site📅 Started Aug 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →